Drug treatments for schizophrenia.
作者信息
Adams C, Wilson P, Gilbody S, Bagnall A M, Lewis R
机构信息
NHS Centre for Reviews and Dissemination, University of York, UK.
出版信息
Qual Health Care. 2000 Mar;9(1):73-9. doi: 10.1136/qhc.9.1.73.
Abstract
摘要
相似文献
1
Drug treatments for schizophrenia.精神分裂症的药物治疗
Qual Health Care. 2000 Mar;9(1):73-9. doi: 10.1136/qhc.9.1.73.
2
[Expensive but nevertheless cost effect? Pharmacoeconomics of atypical neuroleptics].[价格昂贵但仍具成本效益？非典型抗精神病药物的药物经济学]
Pharm Unserer Zeit. 2002;31(6):572-6. doi: 10.1002/1615-1003(200211)31:6<572::AID-PAUZ572>3.0.CO;2-D.
3
Policy toward second-generation antipsychotic drugs: a cautionary note.
Psychiatr Serv. 2008 May;59(5):521-2. doi: 10.1176/ps.2008.59.5.521.
4
Antipsychotic drugs: the costs and benefits.抗精神病药物：成本与效益
Harv Ment Health Lett. 2007 Mar;23(9):5-6.
5
[The contribution of clinical pharmacy: optimization of administration in schizophrenic disorders].[临床药学的贡献：精神分裂症治疗中给药方案的优化]
Pharm Unserer Zeit. 2002;31(6):566-71. doi: 10.1002/1615-1003(200211)31:6<566::AID-PAUZ566>3.0.CO;2-1.
6
Cost-effectiveness of schizophrenia pharmacotherapy.精神分裂症药物治疗的成本效益
Am J Psychiatry. 2007 Apr;164(4):678; author reply 678-9. doi: 10.1176/ajp.2007.164.4.678a.
7
Methods of pharmacoeconomic evaluation of psychopharmacologic therapies for patients with schizophrenia.精神分裂症患者精神药物治疗的药物经济学评估方法
J Psychiatry Neurosci. 1997 Jul;22(4):256-66.
8
Delaying time to relapse in schizophrenia. The role of long-acting injectable antipsychotics.延迟精神分裂症的复发时间。长效注射用抗精神病药物的作用。
Manag Care. 2014 Apr;23(4 Suppl 1):2-3.
9
The NIMH-CATIE Schizophrenia Study: what did we learn?美国国立精神卫生研究所-抗精神病药物干预有效性临床试验精神分裂症研究：我们学到了什么？
Am J Psychiatry. 2011 Aug;168(8):770-5. doi: 10.1176/appi.ajp.2011.11010039.
10
Which atypical antipsychotic.哪种非典型抗精神病药物。
Br J Psychiatry. 1998 Feb;172:106-9. doi: 10.1192/bjp.172.2.106.
引用本文的文献
1
Quetiapine. A review of its use in the management of schizophrenia.喹硫平。关于其在精神分裂症治疗中应用的综述。
CNS Drugs. 2004;18(3):173-99. doi: 10.2165/00023210-200418030-00004.
2
Amisulpride: a review of its use in the management of schizophrenia.氨磺必利：其在精神分裂症治疗中的应用综述
Drugs. 2001;61(14):2123-50. doi: 10.2165/00003495-200161140-00014.
本文引用的文献
1
Cost analysis of the treatment of schizophrenia in the UK: a comparison of olanzapine and haloperidol.英国精神分裂症治疗的成本分析：奥氮平与氟哌啶醇的比较
Pharmacoeconomics. 1998 May;13(5 Pt 2):575-88. doi: 10.2165/00019053-199813050-00010.
2
Pragmatic randomised controlled trials in psychiatry.精神病学中的实用随机对照试验。
Br J Psychiatry. 1999 Sep;175:217-23. doi: 10.1192/bjp.175.3.217.
3
Myocarditis and cardiomyopathy associated with clozapine.与氯氮平相关的心肌炎和心肌病。
Lancet. 1999 Nov 27;354(9193):1841-5. doi: 10.1016/s0140-6736(99)10385-4.
4
Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial.自杀与精神分裂症：氯氮平与InterSePT研究。国际氯氮平/利培酮自杀预防试验。
J Clin Psychiatry. 1999;60 Suppl 12:47-50.
5
Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.氯氮平：对其治疗精神分裂症的药物经济学效益评估
Pharmacoeconomics. 1993 Aug;4(2):131-56. doi: 10.2165/00019053-199304020-00007.
6
7
Beyond conflict of interest. Sponsored drug trials show more-favourable outcomes.超越利益冲突。赞助的药物试验显示出更有利的结果。
BMJ. 1999 Feb 13;318(7181):465.
8
Content and quality of 2000 controlled trials in schizophrenia over 50 years.50年来2000项精神分裂症对照试验的内容与质量。
BMJ. 1998 Oct 31;317(7167):1181-4. doi: 10.1136/bmj.317.7167.1181.
9
Randomized controlled trials in Archives of General Psychiatry (1959-1995): a prevalence study.《普通精神病学文献》（1959 - 1995年）中的随机对照试验：一项患病率研究。
Arch Gen Psychiatry. 1998 Aug;55(8):754-5. doi: 10.1001/archpsyc.55.8.754.
10
Beyond conflict of interest. Transparency is the key.超越利益冲突。透明度是关键。
BMJ. 1998 Aug 1;317(7154):291-2. doi: 10.1136/bmj.317.7154.291.
Zotero 插件